Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results

22.02.2023 - REDWOOD CITY, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) - Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the 'Company'), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and ...

Related Keywords

Japan ,United States ,France ,French ,Japanese ,America ,Pulmonx Zephyr Endobronchial ,Brian Johnston ,Exchange Commission ,Gilmartin Group ,Securities Exchange ,Pulmonx Corporation Nasdaq ,Pulmonx Corporation ,Zephyr Valves ,Glen French ,Chief Executive ,Zephyr Valve ,Conference Call ,Investor Relations ,Securities Act ,Securities Exchange Act ,Device Exemption ,Risk Factors ,Quarterly Report ,Annual Report ,Zephyr Endobronchial Valve ,Chartis Pulmonary Assessment System ,Lung Analysis Platform ,Months Ended December ,Reported Revenue ,Constant Currency Revenue ,Net Loss ,